<bill session="118" type="s" number="723" updated="2024-07-24T15:23:29Z">
  <state datetime="2023-03-08">REFERRED</state>
  <status>
    <introduced datetime="2023-03-08"/>
  </status>
  <introduced datetime="2023-03-08"/>
  <titles>
    <title type="display">Access to Prescription Digital Therapeutics Act of 2023</title>
    <title type="short" as="introduced">Access to Prescription Digital Therapeutics Act of 2023</title>
    <title type="official" as="introduced">A bill to amend titles XVIII and XIX of the Social Security Act to provide for coverage of prescription digital therapeutics under such titles, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="S001181"/>
  <cosponsors>
    <cosponsor bioguide_id="B001243" joined="2023-03-08"/>
    <cosponsor bioguide_id="B001288" joined="2023-03-08"/>
    <cosponsor bioguide_id="B001305" joined="2023-06-07"/>
    <cosponsor bioguide_id="C001047" joined="2023-03-08"/>
  </cosponsors>
  <actions>
    <action datetime="2023-03-08">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2023-03-08" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSFI" name="Senate Finance" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="118" type="h" number="1458" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Business records"/>
    <term name="Civil actions and liability"/>
    <term name="Computers and information technology"/>
    <term name="Digital media"/>
    <term name="Health care costs and insurance"/>
    <term name="Internet, web applications, social media"/>
    <term name="Medicaid"/>
    <term name="Medicare"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2023-04-17T14:53:35Z" status="Introduced in Senate">Access to Prescription Digital Therapeutics Act of 2023

This bill provides for Medicare and Medicaid coverage of prescription digital therapeutics (i.e., software applications that are used to prevent, manage, or treat medical conditions). The Centers for Medicare &amp; Medicaid Services must establish a Medicare payment methodology for payments to manufacturers that takes into account certain factors (e.g., ongoing use); manufacturers must report specified information about private payors, subject to civil penalties.</summary>
</bill>
